Home Cart Sign in  
Chemical Structure| 73334-07-3 Chemical Structure| 73334-07-3

Structure of Iopromide
CAS No.: 73334-07-3

Chemical Structure| 73334-07-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Iopromide is a non-ionic, water-soluble X-ray contrast agent for intravascular administration.

Synonyms: Ultravist

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Iopromide

CAS No. :73334-07-3
Formula : C18H24I3N3O8
M.W : 791.11
SMILES Code : O=C(N(CC(O)CO)C)C1=C(I)C(NC(COC)=O)=C(I)C(C(NCC(O)CO)=O)=C1I
Synonyms :
Ultravist
MDL No. :MFCD00867924
InChI Key :DGAIEPBNLOQYER-UHFFFAOYSA-N
Pubchem ID :3736

Safety of Iopromide

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302+H312-H315-H318-H411
Precautionary Statements:P264-P270-P273-P280-P301+P312+P330-P302+P352+P312-P305+P351+P338+P310-P332+P313-P391-P501
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HK-2 cells 0, 20, 40, 80, or 160 mg I/ml 2 hours To explore the effect of IOP on cell viability, results showed that IOP significantly decreased cell viability at concentrations of 40-160 mg I/ml Biosci Rep. 2020 Feb 28;40(2):BSR20193253
Human articular chondrocytes 15.6 mg/mL 2 and 6 hours To evaluate the toxic effects of Iopromide on human articular chondrocytes. Results showed that the Iopromide-treated group had the lowest cell viability and proliferation, with changes in cell morphology and reduced extracellular matrix formation. J Orthop Surg Res. 2017 Jun 26;12(1):98
Renal proximal tubular (RPT) cells 80 mg/mL 1 hour To evaluate the effect of iopromide on RPT cell membrane damage, results showed that iopromide significantly increased LDH release, and rhMG53 attenuated this damage in a dose-dependent manner. Acta Pharmacol Sin. 2020 Nov;41(11):1457-1464
Renal proximal tubular (RPT) cells 20, 40, 80 mg/mL To evaluate the effect of iopromide on RPT cell viability, results showed that iopromide decreased RPT cell viability in a dose- and time-dependent manner. Acta Pharmacol Sin. 2020 Nov;41(11):1457-1464
Human renal tubular epithelial cells (HK-2) 150 mgI/mL 3 hours To investigate the effect of Iopromide on HK-2 cell viability, results showed a dose-dependent decrease in cell viability. Front Pharmacol. 2021 Dec 31;12:761908
NRK-52E cells 150 mg I/ml 3 hours Establish in vitro model of contrast-induced acute kidney injury and observe cell viability and inflammatory response Ren Fail. 2020 Nov;42(1):270-281

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Contrast-induced acute kidney injury model Intraperitoneal injection 3.7 g iodine/kg Single dose To investigate the effect of IOP on mouse kidneys, results showed that IOP injection induced acute kidney injury Biosci Rep. 2020 Feb 28;40(2):BSR20193253
C57BL/6 mice Contrast-induced acute kidney injury model Intraperitoneal injection 3.7 g iodine/kg Single dose To study the effect of IOP on mouse kidneys, results showed that IOP injection caused acute kidney injury Biosci Rep. 2020 Feb 28;40(2):BSR20193253
Sprague Dawley (SD) rats Contrast-induced acute kidney injury (CI-AKI) model Intravenous injection 1600 mg I/kg Single dose, evaluated after 24 hours To evaluate the CI-AKI model induced by iopromide and the protective effect of rhMG53, results showed that rhMG53 pretreatment attenuated iopromide-induced renal function impairment and tubular cell apoptosis. Acta Pharmacol Sin. 2020 Nov;41(11):1457-1464
New Zealand rabbits Contrast-induced nephropathy model Intravenous injection 24 ml/kg Single injection, killed after 24 hours To evaluate the effect of iopromide on renal function and the protective effect of nanoliposomes. Results showed that iopromide significantly increased serum creatinine and blood urea nitrogen levels, while the nanoliposome group significantly reduced these indicators and decreased renal damage. Front Mol Biosci. 2021 Jul 6;8:681849
Sprague-Dawley rats Contrast-induced acute kidney injury model Intravenous injection 2.9 g/kg Single dose Study the acute kidney injury model induced by Iopromide and observe renal function and morphological changes Ren Fail. 2020 Nov;42(1):270-281
Sprague-Dawley rats Contrast-induced nephropathy model Intravenous injection 2 g/kg Single dose, lasting 24 hours To investigate the role of Iopromide in a contrast-induced nephropathy model, results showed that Iopromide caused renal dysfunction and tubular injury. J Clin Med. 2019 Jan 27;8(2):147

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.26mL

0.25mL

0.13mL

6.32mL

1.26mL

0.63mL

12.64mL

2.53mL

1.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records